Role of flow‐cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B‐cell acute lymphoblastic leukemia

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cytometry. Part B, Clinical cytometry

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/cyto.b.21605PMID 29220871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Acute Lymphoblastic Leukemia in Children and Adolescents

  2018cited by this paper
• Significance of CD66c expression in childhood acute lymphoblastic leukemia.

  2014cited by this paper
• Expression of CD25 is a specific and relatively sensitive marker for the Philadelphia chromosome (BCR-ABL1) translocation in pediatric B acute lymphoblastic leukemia.

  2014cited by this paper
• CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia.

  2013cited by this paper
• Cytogenetic Nomenclature: Changes in the ISCN 2013 Compared to the 2009 Edition

  2013cited by this paper
• Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

  2012cited by this paper
• CD66c expression in B‐cell acute lymphoblastic leukemia: strength and weakness

  2011cited by this paper
• Prognostic significance of immunophenotypic and karyotypic features of Philadelphia positive B‐lymphoblastic leukemia in the era of tyrosine kinase inhibitors

  2011cited by this paper
• Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.

  2009cited by this paper
• Expression of CD66c and CD25 in acute lymphoblastic leukemia as a predictor of the presence of BCR/ABL rearrangement.

  2008cited by this paper
• Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia

  2007cited by this paper
• Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

  2007cited by this paper
• Management of acute lymphoblastic leukemia in older patients.

  2006cited by this paper
• Myeloid antigens in childhood lymphoblastic leukemia:clinical data point to regulation of CD66c distinct from other myeloid antigens

  2005cited by this paper
• Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia

  2004cited by this paper
• Philadelphia ChromosomePositive Leukemias: From Basic Mechanisms to Molecular Therapeutics

  2003cited by this paper
• Immunophenotypes and Outcome of Philadelphia Chromosome-Positive and -Negative Thai Adult Acute Lymphoblastic Leukemia

  2003cited by this paper
• [Immunophenotypic features of bcr/abl fusion transcript-positive B-lineage acute lymphoblast leukemia].

  2003cited by this paper
• Philadelphia chromosome-positive acute lymphocytic leukemia.

  2001cited by this paper
• Clinical and biological significance of CD34 expression in acute leukemia.

  2001cited by this paper
• Adult precursor B-ALL with BCR/ABL gene rearrangements displays a unique immunophenotype based on the pattern of CD10, CD34, CD13 and CD38 expression

  2001cited by this paper
• Outcome of Philadelphia Chromosome-Positive Adult Acute Lymphoblastic Leukemia

  2000cited by this paper
• Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease

  1999cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• The Molecular Biology of Chronic Myeloid Leukaemia

  1998cited by this paper
• Aberrant expression of KOR-SA3544 antigen in childhood acute lymphoblastic leukemia predicts TEL-AML1 negativity

  1998cited by this paper
• Expression of CD25 (interleukin-2 receptor alpha chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993. Eastern Cooperative Oncology Group/Medical Research Council.

  1997cited by this paper
• Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993

  1997cited by this paper
• Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia

  1997cited by this paper
• The molecular biology of chronic myeloid leukaemia.

  1996cited by this paper
• The molecular biology of chronic myeloid leukaemia.

  1996cited by this paper
• BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.

  1995influential reference
• A novel monoclonal antibody, KOR-SA3544 which reacts to Philadelphia chromosome-positive acute lymphoblastic leukemia cells with high sensitivity.

  1995cited by this paper
• Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia.

  1994cited by this paper
• Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia

  1992cited by this paper
• Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762).

  1992cited by this paper
• Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction.

  1991cited by this paper
• Minimal Residual Disease in Acute Leukemia

  1984cited by this paper

• Low-Intensity CD66c Expression Orchestrates an Immunosuppressive Niche Promoting Residual Disease in Pediatric ProB Acute Lymphoblastic Leukemia

  2026cites this paper
• Frequent TCR rearrangements in pediatric B-cell lymphoblastic acute leukemia: genomic and phenotypic features

  2025cites this paper
• Flow cytometry as a predictive modality for translocation (9;22) and translocation (12;21) in B acute lymphoblastic leukemia

  2025cites this paper
• Genetics of B-Cell Acute Lymphoblastic Leukemia (B-ALL): Recent Updates and Indian Perspective

  2025cites this paper
• CD146 Molecule Expression in B Cells Acute Lymphoblastic Leukemia (B-ALLs): A Flow-Cytometric Marker for an Accurate Diagnostic Workup

  2024cites this paper
• CD36 cell surface expression as a surrogate marker to identify ABL/JAK-class kinase fusions in pediatric BCP-ALL

  2024cites this paper
• A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens

  2024cites this paper
• Prognostic value of cross‐lineage expression of the myeloid‐associated antigens CD13 and CD33 in adult B‐lymphoblastic leukemia: A large real‐world study of 1005 patients

  2023cites this paper
• Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab

  2023cites this paper
• The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia following Allogeneic Stem Cell Transplantation

  2023cites this paper
• Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.

  2023cites this paper
• Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 2: B-/T-Cell Acute Lymphoblastic Leukemias

  2023cites this paper
• Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction

  2022cites this paper
• Association of Minimal Residual Disease by a Single-Tube 8-Color Flow Cytometric Analysis With Clinical Outcome in Adult B-Cell Acute Lymphoblastic Leukemia.

  2022cites this paper
• Electrochemiluminescence Determination of a Specific Sequence of the BCR/ABL Gene Related to Chronic Myelogenous Leukemia with a Ferrocene-Labelled Molecular Beacon and a Gold Nanoparticle (AuNP)-Luminol-Silica Nanocomposite

  2021cites this paper
• Systematic application of fluorescence in situ hybridization and immunophenotype profile for the identification of ZNF384 gene rearrangements in B cell acute lymphoblastic leukemia

  2021cites this paper
• Dual-modal label-free genosensor based on hemoglobin@gold nanocluster stabilized graphene nanosheets for the electrochemical detection of BCR/ABL fusion gene.

  2020cites this paper
• Association of Myeloid Aberrant Antigens and the Presence of BCR-ABL Gene Re-arrangements in ALL Patients

  2020cites this paper
• Applications and efficiency of flow cytometry for leukemia diagnostics

  2019cites this paper
• Spectrum and Immunophenotypic Profile of Acute Leukemia: A Tertiary Center Flow Cytometry Experience

  2019influential citation
• Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B‐acute lymphoblastic leukemia

  2019cites this paper
• Issue Highlights—May 2018 (94B3)

  2018cites this paper